Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
Note: employees of the Institute are marked with an asterisk (*) in the list of authors.
Web of Science ,
Scopus
Authors
Sultankulova K., Chervyakova O., Myrzakhmetova B., Nakhanov A., Nurpeisova A., Zhugunissov K., Assanzhanova Nurikaa., Nurabayev S., Kerimbayev A. Yershebulov Z., Burashev Y., Kulmagambetov I., Davlyatshin T., * Sergeeva M., * Buzitskaya Z., * Stukova M., Kutumbetov L.
Publication type
Journal article
Indexed in


Info:
Published in
EClinicalMedicine
Year of publication
2022
Volume
50
Pages
101526